Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Consuelo Rayón, Sylvie Castaigné et al.|Blood|2009Cited by 251
Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia GroupLionel Adès, Pierre Fenaux, Sylvie Chevret et al.|Journal of Clinical Oncology|2006Cited by 166
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsLionel Adès, Pierre Fenaux, Miguel Á. Sanz et al.|Blood|2007Cited by 157
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupCéline Callens, Sylvie Chevret, JM Cayuela et al.|Leukemia|2005Cited by 139
Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group ExperienceCharikleia Kelaïdi, Lionel Adès, Sylvie Chevret et al.|Journal of Clinical Oncology|2009Cited by 120